Life Sciences Opportunities in India & China: From Innovation to Commercialization
30 September 2009
China and India are emerging as major players in the life sciences industry. Both countries have a wealth of top talent as well as rapidly-improving resources for the industry. Both countries also constitute important current and potential markets for drugs, devices and diagnostics, and are also projected to be major sources of innovation in the not-too-distant future. This panel will explore the significant opportunities in China and India, in terms not only of expanding operations to both countries, but also in terms of working with innovative companies that originate from China and India.
Moderator:
- David A. Charapp, Special Counsel, Foley & Lardner LLP
Panelists:
- Stephen A. Bent, Partner, Foley & Lardner LLP
- Friedhelm Blobel, Ph.D., President, CEO, Director, SciClone Pharmaceuticals
- Kim Kamdar, Ph.D., Principal at Domain Associates
- Sanjay Shukla, M.D., M.S., Chief Executive Officer, RxMD
Related Insights
20 May 2024
Events
Lunch & Learn – An AI Conversation
Join the Utah Tech Community for a lunch & learn exploring the evolution of AI and its implications for founders and finance teams.
23 April 2024
Article
The Rubber Meets the Road on State and Federal Vehicle Emissions Strategies
March and April have been busy months for vehicle emission regulation in the U.S. On March 20 and March 29 respectively, the U.S. Environmental Protection Agency issued a set of final emission rules setting stringent emission standards for all vehicle classes.
09 May 2024
Events
The Changing Hospital Landscape
Foley partner Larry Vernaglia, co-chair of the firm’s Providers of Health Care Services Area of Focus, is moderating a panel at the 2024 Convergence Forum titled “The Changing Hospital Landscape.”